Physician profile
Syed Ali
NPI 1619460383
$26,464.49
in general payments reported to CMS, 2019-2025
21 companies · $13K in 2025
The $13K reported for 2025 was more than what 84% of Clinical Cardiac Electrophysiology providers received nationally (typical 2025 total: $2,477).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $338 · 2022: $505 · 2023: $3,281 · 2024: $8,936 · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $15K · Travel and Lodging: $6,403 · Food and Beverage: $4,058 · Education: $161.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $15,000.00 |
| Travel and Lodging | $6,403.14 |
| Food and Beverage | $4,057.50 |
| Education | $161.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $8,466.83 | 2024-2025 | Tacticath, Assurity, Ensite |
| Medtronic, INC. | $7,739.18 | 2021-2025 | Advisa Dr Mri Surescan, Corevalve Evolut R, Azure Xt Dr Mri Surescan |
| Boston Scientific Corporation | $4,720.70 | 2024-2025 | Watchman Access System |
| Biotronik INC. | $1,708.96 | 2024-2025 | Amvia Edge, Solia, Pamira |
| Philips North America LLC | $1,058.08 | 2025 | Lm Undivided, Igt Devices Undivided, Laser Parts Other |
| Inari Medical, INC. | $1,019.12 | 2023 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $774.23 | 2021-2024 | Impella |
| Cvrx, INC. | $285.84 | 2024 | Barostim Neo System |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $178.74 | 2021-2025 | Lifevest |
| Biosense Webster, INC. | $160.01 | 2025 | Carto 3 |
| Astrazeneca Pharmaceuticals LP | $135.81 | 2021-2024 | Andexxa |
| Novartis Pharmaceuticals Corporation | $52.79 | 2021-2022 | |
| Novo Nordisk INC | $29.21 | 2025 | Ozempic, Rybelsus |
| Acist Medical Systems, INC. | $24.17 | 2024 | |
| Teleflex LLC | $20.75 | 2023 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cordis US Corp. | $17.36 | 2025 | Mynx Control Venous |
| Lexicon Pharmaceuticals, INC. | $16.42 | 2023 | Inpefa |
| Pfizer INC. | $16.26 | 2021 | |
| Cleerly, INC. | $13.78 | 2023 | Cleerly Labs |
| W. L. Gore & Associates, INC. | $13.58 | 2024 | Gore Cardioform Septal Occluder |
| Janssen Pharmaceuticals, INC | $12.67 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Syed Ali listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.